AstraZeneca’s Rockville Facility Executive Director, Brian Stamper, emphasized the company’s dedication to the pledge. “We ...
The Chesapeake and Delaware are the main office buildings on the south campus and formally are on the market, said Michele L.
The pact with Mankind Pharma, announced in March 2024, was an exclusive agreement for distribution of budesonide and ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
AstraZeneca’s expanding footprint in the US includes, among others: A state-of-the-art R&D centre in Kendall Square, Cambridge, Massachusetts; A next generation manufacturing facility for biologics in ...
AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...
The new investments will expand manufacturing sites in Maryland, Texas and California. But AstraZeneca shares have fallen nearly 6% this year, underperforming a near 9% rise in the wider European ...
many of the projects AstraZeneca outlined are, in fact, not exactly new. For instance, the company announced plans for its cell therapy facility in Rockville, Maryland back in February.
AstraZeneca has announced a major expansion ... spend $2bn to bolster its manufacturing capacity in states including Maryland and Texas as well as on the west coast. This would bring its total ...
(RTTNews) - British drug maker AstraZeneca Plc (AZN.L ... a next generation manufacturing facility for biologics in Maryland; Cell therapy manufacturing capacity on the West and East Coasts ...
AstraZeneca made headlines for several reasons on Tuesday ... The investment will also support creation of a new next generation manufacturing facility, focused on biologics, in Maryland as well as ...